Simon Hirst

Simon Hirst serves as the Chief Executive and founder of Sygnature Discovery since its inception in 2004. In addition, Simon Hirst is a non-executive Director at Peak Proteins Ltd, contributing to the growth of a bio-science company focused on gene-to-structure services. As a Board Member and Co-Founder of Step Pharmaceuticals, Simon Hirst is involved in the discovery and development of small molecule drugs for immunology and cancer. Previous roles include Managing Director at CombiPure Ltd and Associate Director of Medicinal Chemistry at OSI Pharmaceuticals, where responsibilities encompassed lead generation, computational chemistry, and project management. Simon Hirst began a career at AstraZeneca Pharmaceuticals as a Senior Research Chemist. Academic qualifications include a PhD in Organic Chemistry from the University of Nottingham and a Certificate of Company Direction from the Institute of Directors.